Further research of the signaling pathways that regulate 4E-BP1 phosphorylation in Xp11.2 RCC may reveal additional therapeutic strategies to attenuate unrestricted protein biosynthesis in this cancer. The gene discussed is EIF4EBP1; the disease is cancer.